Hochhaus et al. Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment. Blood. 2008;111:1039-1043.

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: American Society of Hematology 2008
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464565/
http://dx.doi.org/10.1182/blood-2008-05-158873
Descripción
Sumario:

Ejemplares similares